Wall Street analysts expect CME Group Inc (NASDAQ:CME) to announce $1.50 earnings per share for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for CME Group’s earnings, with the highest EPS estimate coming in at $1.63 and the lowest estimate coming in at $1.43. CME Group reported earnings per share of $1.90 during the same quarter last year, which would suggest a negative year-over-year growth rate of 21.1%. The company is expected to announce its next quarterly earnings report on Wednesday, November 4th.
According to Zacks, analysts expect that CME Group will report full-year earnings of $7.03 per share for the current fiscal year, with EPS estimates ranging from $6.85 to $7.22. For the next financial year, analysts forecast that the business will post earnings of $7.10 per share, with EPS estimates ranging from $6.33 to $7.65. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research analysts that follow CME Group.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 29th. The financial services provider reported $1.63 EPS for the quarter, beating the Zacks’ consensus estimate of $1.62 by $0.01. The firm had revenue of $1.18 billion during the quarter, compared to the consensus estimate of $1.20 billion. CME Group had a net margin of 46.39% and a return on equity of 9.93%. The firm’s revenue was down 7.1% compared to the same quarter last year. During the same quarter last year, the firm earned $1.76 earnings per share.
CME has been the subject of several recent analyst reports. Deutsche Bank decreased their price objective on shares of CME Group from $196.00 to $178.00 and set a “buy” rating for the company in a report on Thursday, July 30th. Bank of America decreased their price objective on shares of CME Group from $194.00 to $180.00 and set a “neutral” rating for the company in a report on Friday, July 10th. Oppenheimer reaffirmed a “buy” rating on shares of CME Group in a report on Wednesday, July 29th. BidaskClub downgraded shares of CME Group from a “sell” rating to a “strong sell” rating in a report on Tuesday, July 14th. Finally, Credit Suisse Group decreased their price objective on shares of CME Group from $190.00 to $183.00 and set a “neutral” rating for the company in a report on Tuesday, June 23rd. Four analysts have rated the stock with a sell rating, eight have given a hold rating and seven have assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $187.88.
NASDAQ:CME traded down $2.27 during mid-day trading on Friday, reaching $169.62. The stock had a trading volume of 2,038,771 shares, compared to its average volume of 1,478,693. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The business has a 50 day simple moving average of $169.81 and a 200 day simple moving average of $179.32. The firm has a market capitalization of $60.68 billion, a price-to-earnings ratio of 25.58, a PEG ratio of 5.59 and a beta of 0.30. CME Group has a twelve month low of $131.80 and a twelve month high of $225.36.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Thursday, September 10th will be issued a dividend of $0.85 per share. This represents a $3.40 dividend on an annualized basis and a dividend yield of 2.00%. The ex-dividend date is Wednesday, September 9th. CME Group’s payout ratio is 50.00%.
In related news, Director Martin J. Gepsman sold 5,000 shares of the stock in a transaction dated Wednesday, September 2nd. The shares were sold at an average price of $173.52, for a total transaction of $867,600.00. Also, Director William R. Shepard bought 1,229 shares of the company’s stock in a transaction that occurred on Thursday, June 11th. The shares were purchased at an average price of $178.10 per share, with a total value of $218,884.90. Following the transaction, the director now directly owns 2,000 shares in the company, valued at $356,200. The disclosure for this purchase can be found here. Insiders have sold a total of 16,500 shares of company stock valued at $2,810,630 over the last ninety days. 1.20% of the stock is owned by insiders.
Several institutional investors have recently made changes to their positions in the stock. Private Vista LLC increased its position in CME Group by 2.3% in the 2nd quarter. Private Vista LLC now owns 2,834 shares of the financial services provider’s stock valued at $461,000 after acquiring an additional 65 shares in the last quarter. Verus Capital Partners LLC boosted its stake in shares of CME Group by 0.9% in the 1st quarter. Verus Capital Partners LLC now owns 7,245 shares of the financial services provider’s stock valued at $1,253,000 after purchasing an additional 67 shares during the last quarter. Buckley Wealth Management LLC boosted its stake in shares of CME Group by 4.0% in the 2nd quarter. Buckley Wealth Management LLC now owns 1,789 shares of the financial services provider’s stock valued at $291,000 after purchasing an additional 68 shares during the last quarter. Coe Capital Management LLC boosted its stake in shares of CME Group by 0.6% in the 2nd quarter. Coe Capital Management LLC now owns 11,758 shares of the financial services provider’s stock valued at $1,911,000 after purchasing an additional 69 shares during the last quarter. Finally, Ninety One SA PTY Ltd boosted its stake in shares of CME Group by 0.7% in the 2nd quarter. Ninety One SA PTY Ltd now owns 10,224 shares of the financial services provider’s stock valued at $1,667,000 after purchasing an additional 70 shares during the last quarter. Institutional investors and hedge funds own 84.24% of the company’s stock.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Further Reading: What is range trading?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.